BeautyHealth reported a strong first quarter with net sales increasing by 58.6% to $75.4 million. The company raised its full-year net sales guidance to $330-340 million, reflecting confidence in its growth plan.
Net sales increased by 58.6% to $75.4 million compared to Q1 2021.
Delivery Systems net sales increased to $41.6 million, driven by the successful launch of Syndeo.
Consumables net sales increased to $33.8 million, reflecting continued strong demand.
The company increased its full-year net sales guidance to $330.0 million - $340.0 million.
BeautyHealth increased its fiscal 2022 guidance and now expects net sales in the range of $330.0 million to $340.0 million, up from the previous outlook for $320.0 million to $330.0 million. The Company also reaffirmed its outlook for adjusted EBITDA of approximately $50.0 million.
Visualization of income flow from segment revenue to net income